Biotech Values

[GratziPrego]

RE: GENR, Seems to have little or no chance due to the following:

Bringing EVIZON to the market in the near future seems highly unlikely due to all the Clinical Trials and FDA Approval necessary, these are barriers to success.

There are a lot of choices for investors to choose from as far as Biotech stocks (why choose GENR? a lot of stiff competition as far as large selection of Biotech stocks to choose)

The Press Releases recently have yielded very little reaction, except a few spikes that are short-lived and result in pull backs down to much lower prices. (not enough investor confidence at the $1.90+ level)